Vic Tapson

Dr. Tapson became interested in acute DVT/PE in the early 1990s, with his earliest research in catheter-directed PE therapy and MR imaging of acute and chronic DVT. He continued with research in all areas of acute VTE, and at the same time, co-funded the Duke Lung Transplant and Duke Pulmonary Hypertension Programs. He enrolled patients in ICOPER in 1990s, and served as PI for a number of national and international PE trials and registries including IMPROVE, NABOR, ENDORSE, OPTALYSE PE, the TAFI inhibitor trial and the BiO2 Angel catheter trial. He served as co-PI for DVT-FREE, the FLARE trial, and many others. After joining Inari, he stepped down from the executive committee for HI PEITHO and Thrombolex trials. He has seen either inpatients or outpatients with acute or chronic PE as well as pulmonary hypertension patients almost daily for decades. He ran Covid trials at Cedars during the pandemic. He was elected to the Royal College of Physicians in 2010. Dr. Tapson has lectured on PE in more than 50 countries.